Recap: Burning Rock Biotech Q2 Earnings

Burning Rock Biotech BNR reported its Q2 earnings results on Wednesday, August 31, 2022 at 05:30 AM.

Here's what investors need to know about the announcement.

Burning Rock Biotech missed estimated earnings by 5.71%, reporting an EPS of $-0.37 versus an estimate of $-0.35.

Revenue was down $179 thousand from the same period last year.

Last quarter the company missed on EPS by $0.03 which was followed by a 1.67% drop in the share price the next day.

Here's a look at Burning Rock Biotech's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.36	-0.27	-0.25	-0.15
EPS Actual	-0.39	-0.38	-0.25	-0.30
Revenue Estimate	20.81M	21.47M	20.15M	21.41M
Revenue Actual	21.38M	23.12M	19.65M	19.71M

To track all earnings releases for Burning Rock Biotech visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar